Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
Chad J. Creighton(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Aňa Lluch(Hospital Clínico Universitario de Valencia), Joe W. Gray(University of Newcastle Australia), C. Kent Osborne(Texas Oncology), Adrian V. Lee(Baylor College of Medicine), Xiaoyong Fu(King University), Susan G. Hilsenbeck(Baylor College of Medicine), Ana M. González-Angulo(The University of Texas MD Anderson Cancer Center), Angelo Casà(Baylor College of Medicine), Yiqun Zhang(Baylor College of Medicine), Bryan T. Hennessy(Royal College of Surgeons in Ireland), Powell H Brown(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center)
Cited by 258
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k